Diet Pills Market Size Worth $3,399.53 Million By 2032 | CAGR: 10.5%

Diet Pills Market Size Worth $3,399.53 Million By 2032 | CAGR: 10.5%

The global diet pills market size is expected to reach USD 3,399.53 million by 2032, according to a new study by Polaris Market Research. The report “Diet Pills Market Share, Size, Trends, Industry Analysis Report, By Product Type (Prescription Based Drugs, Over the Counter Drugs, and Herbal Supplements); By Distribution Channel; By Application; By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diet pill demand is being fueled by government measures to combat obesity. The prevalence of issues, including irrational weight gain, diabetes, and obesity, is anticipated to boost sales of diet pills. According to the Office of Disease Prevention and Health Promotion, In the United States, 1 in 5 children and adults and 2 in 5 adults are obese, while many more are overweight. The goal of Healthy People 2030 is to encourage healthy eating and regular exercise so that people can achieve and keep a healthy weight. Type 2 diabetes, heart conditions, stroke, and some cancers are just a few of the significant health issues that obesity is associated with. The public is becoming more aware of the need for prescriptions for dietary supplements, and there is a spike in the popularity of consuming these supplements.

Nowadays, fitness enthusiasts control nutritionists' role in the prescription of diet medications. Diet pill manufacturers frequently pay some attention to these trends and place a greater emphasis on their goods' strategic marketing. The medical research field is developing, causing the demand for diet pills to increase over the forecast period. Several businesses have successfully introduced a variety of nutritional pills on the market. For instance, in July 2021, Wegovy (liraglutide) injection (2.4 mg once weekly) was approved by the U.S. Food and Drug Administration to be used in conjunction with a low-calorie diet and enhanced physical activity in adult people who are obese or weight-related disorder (such as high cholesterol, type 2 diabetes). Thus, these factors are supporting the growth of the market.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:

Additionally, non-prescription diet pills are dietary supplements that can be purchased or used without a prescription from a doctor. The components in these supplements frequently promise to aid in weight loss by boosting metabolism, reducing hunger, or preventing the absorption of carbohydrates or fats. Caffeine, green tea extract, chromium, garcinia cambogia, and hoodia gordonii are typical components in over-the-counter diet pills. Therefore, the demand for over-the-counter pills is rising.

Diet Pills Market Report Highlights

  • The offline segment is projected to grow at a highest CAGR over the study period. In-person sales of diet tablets typically take place in retail establishments and hospital pharmacies.
  • Herbal supplements segment accounted for significant revenue share. The desire for even more vegan and plant-based diet alternatives is likely to lead to favorable growth.
  • Asia-Pacific is expected to grow at a significant rate over the projected period due to increasing health consciousness among consumers, increasing disposable income, and demographic changes.
  • The global players include Arena Pharmaceuticals, Currax Pharmaceuticals, Chong’s Health Care, Cortislim, Novo Nordisk, Nanjing Chang'ao Pharmaceutical, Orexigen Therapeutics, TEVA Pharmaceutical, Vivus, Inc., & Zoller Laboratories

Polaris Market Research has segmented the Diet Pills market report based on product type, application, distribution channel, and region:

Diet Pills, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Prescription Based Drugs
  • Over the Counter Drugs
  • Herbal Supplements

Diet Pills, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Metabolism Raising Pills
  • Fat Blocking Pills
  • Appetite Controlling Pills
  • Others

Diet Pills, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Offline Pharmacy
    • Hospital Pharmacy
    • Drug Stores
    • Retails Pharmacy
  • Online Pharmacy

Diet Pills, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa